ICDs Prevent Sudden Death From Hypertrophic Cardiomyopathy - Registry
This article was originally published in The Gray Sheet
A single risk factor for sudden cardiac death in patients with hypertrophic cardiomyopathy may be enough to justify a prophylactic cardioverter defibrillator implant, according to the results of a Medtronic-sponsored registry reported in the July 25 Journal of the American Medical Association
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.